{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Randomized+booster&page=9", "query": { "intervention": "Randomized booster", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 246, "total_pages": 25, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Randomized+booster&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Randomized+booster&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T18:12:39.799Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00751842", "title": "A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "rhGAD65", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Diamyd Therapeutics AB", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "10 Years to 20 Years" }, "enrollment_count": 331, "start_date": "2008-09", "completion_date": "2012-07", "has_results": false, "last_update_posted_date": "2012-10-10", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 43, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Rogers, Arkansas + 40 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00751842" }, { "nct_id": "NCT01992536", "title": "Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningococcal Disease" ], "interventions": [ { "name": "MenABCWY+OMV", "type": "BIOLOGICAL" }, { "name": "MenABCWY+¼OMV", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Novartis Vaccines", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 194, "start_date": "2013-12", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-10-25", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Madera, California • Paramount, California + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Madera", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Louisville", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01992536" }, { "nct_id": "NCT03312699", "title": "Effects of Aging on Primary and Secondary Vaccine Responses", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza", "Hepatitis A", "Typhoid", "Healthy Adults" ], "interventions": [ { "name": "Fluzone® quadrivalent", "type": "BIOLOGICAL" }, { "name": "Fluzone High Dose", "type": "BIOLOGICAL" }, { "name": "Fluad", "type": "BIOLOGICAL" }, { "name": "Vaqta", "type": "BIOLOGICAL" }, { "name": "Typhim Vi", "type": "BIOLOGICAL" }, { "name": "Vivotif", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2017-09-19", "completion_date": "2023-12-31", "has_results": false, "last_update_posted_date": "2024-12-16", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03312699" }, { "nct_id": "NCT02943551", "title": "Dialogue Around Respiratory Illness Treatment", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Respiratory Disease", "Acute Respiratory Infection", "Respiratory Infection", "Upper Respiratory Infection" ], "interventions": [ { "name": "Online Tutorial", "type": "OTHER" }, { "name": "Webinars", "type": "OTHER" }, { "name": "Booster Sessions", "type": "OTHER" }, { "name": "Feedback Reports", "type": "OTHER" }, { "name": "Parent Survey", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Seattle Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "10 Years", "sex": "ALL", "summary": "6 Months to 10 Years" }, "enrollment_count": 2728, "start_date": "2016-07-18", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2019-07-16", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 20, "location_summary": "Paragould, Arkansas • Eureka, California • Durango, Colorado + 16 more", "locations": [ { "city": "Paragould", "state": "Arkansas" }, { "city": "Eureka", "state": "California" }, { "city": "Durango", "state": "Colorado" }, { "city": "Wallingford", "state": "Connecticut" }, { "city": "Bradenton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02943551" }, { "nct_id": "NCT03983499", "title": "Latinos Understanding the Need for Adherence in Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes", "Glycemic Control", "Cardiovascular Risk Factors", "Psychological Distress" ], "interventions": [ { "name": "Special Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "San Diego State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 456, "start_date": "2015-07-16", "completion_date": "2018-12-31", "has_results": false, "last_update_posted_date": "2019-06-12", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03983499" }, { "nct_id": "NCT04368728", "title": "Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "SARS-CoV-2 Infection", "COVID-19" ], "interventions": [ { "name": "BNT162b1", "type": "BIOLOGICAL" }, { "name": "BNT162b2", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" }, { "name": "BNT162b2SA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 46969, "start_date": "2020-04-29", "completion_date": "2023-02-10", "has_results": true, "last_update_posted_date": "2026-03-25", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 154, "location_summary": "Athens, Alabama • Birmingham, Alabama • Huntsville, Alabama + 106 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04368728" }, { "nct_id": "NCT05541393", "title": "Engaging Church Health Ministries to Decrease Coronavirus Disease-19 Vaccine Hesitancy in Underserved Populations", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "Active Intervention Group", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Pennington Biomedical Research Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2023-04-15", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2023-04-27", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 1, "location_summary": "Baton Rouge, Louisiana", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05541393" }, { "nct_id": "NCT03417219", "title": "Mobile Tablet Education to Advance Caregiver Health", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Dementia" ], "interventions": [ { "name": "Education and Skill Building Rehabilitation-mobile (ESBR-m)", "type": "BEHAVIORAL" }, { "name": "Usual Care (UC)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2015-01-01", "completion_date": "2018-06-30", "has_results": true, "last_update_posted_date": "2019-07-15", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03417219" }, { "nct_id": "NCT00779402", "title": "PROvenge Treatment and Early Cancer Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Control", "type": "OTHER" }, { "name": "Sipuleucel-T", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Dendreon", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "MALE", "summary": "18 Years to 80 Years · Male only" }, "enrollment_count": 176, "start_date": "2001-10", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2018-01-29", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 18, "location_summary": "Berkeley, California • Laguna Hills, California • Aurora, Colorado + 13 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Park Ridge", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00779402" }, { "nct_id": "NCT02157168", "title": "Connecting Healthy Women: Examining the Effect of an Intervention From the Effect of Being Reachable", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Contraception", "Sexually Transmitted Infections", "Cervical Cancer" ], "interventions": [ { "name": "Community health worker", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "FEMALE", "summary": "18 Years to 39 Years · Female only" }, "enrollment_count": 2267, "start_date": "2015-03-30", "completion_date": "2016-12-15", "has_results": true, "last_update_posted_date": "2019-04-05", "last_synced_at": "2026-10-23T18:12:39.799Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02157168" } ] }